Domma develops scientifically grounded, non-invasive treatments and a digital accompaniment program for menopause, with a portfolio of nutritional supplements, serums and relaxant preparations. Its product range includes Equilibrio (superfoods and adaptogens), Deseo (a drinkable supplement for libido), Bienestar íntimo (intimate hydrating serum), Descanso (sleep and night-sweat supplement) and Calma (relaxing infusion). The company offers personalized treatment and accompaniment plans and claims more than a thousand subscribers to those plans, plus a community of over 100,000 women. In 2023, Domma — in its second year of activity — reported 350% growth versus 2022. The team has 10 people and is headquartered in Barcelona. Future plans stated by the company include boosting scientific research, developing new biotechnological solutions and digitalizing the accompaniment experience to reach more consumers.

Total raised

$1M

Funding rounds

2

Latest round

Equity

Latest activity

Feb 2024